HSP90AA1 and Parkinson disease: In Parkinson disease, in vitro experiments revealed that HSP90, as well as HSP70/40 could suppress Aβ amyloid self-assembly suggesting that induction of chaperones’ overexpression by pharmacological substances has potential therapeutic value for neurodegenerative diseases [110].